Meros Investment Management, LP Meridian Bioscience Inc Transaction History

Meros Investment Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$23.75 - $31.69 $2.84 Million - $3.79 Million	-119,690 Reduced 35.81%	214,537 $6.53 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $76,964 - $103,826	3,854 Added 1.17%	334,227 $8.68 Million
Q4 2021 Feb 16, 2022	BUY	$17.46 - $21.61 $5.77 Million - $7.14 Million	330,373 New	330,373 $6.74 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Meros Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Meros Investment Management, LP with notifications on news.